International Federation of Biomedical Laboratory Science

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

International Federation of Biomedical Laboratory Science
IFBLS
IFBLS is a global federation of medical laboratory scientists/technologists from 35 countries around the world. Our mission is to promote the development of laboratory professionals and laboratory medicine through education and partnerships.
http://ifbls.org
28 Jun 2021 11:03:03 PM

 General information

International Federation of Biomedical Laboratory Science
IFBLS
International Federation of Biomedical Laboratory Science
IFBLS
IFBLS is a global federation of medical laboratory scientists/technologists from 35 countries around the world. Our mission is to promote the development of laboratory professionals and laboratory medicine through education and partnerships.
33 Wellington Street North
Hamilton
Ontario
L8R 1M7
Canada
communications@ifbls.org
http://ifbls.org

 Governance

Not for Profit
1954
Board of Directors
Anne Lindgren
Past-President
Advisor, Vårdförbundet , Sweden
Alan Wainwright
President
Executive Head of Education, Institute of Biomedical Science, United Kingdom
Cathy Otto
Board Member
Associate Professor in the Department of Clinical Laboratory Sciences at Rutgers-School of Health Professions, United States
Hironori Katayama
Board Member
Chief Biomedical Laboratory Scientist, Nippon Medical School Tama-Nagayama Hospital, Japan
Leila Lany Florento
Board Member
Manager, Biological Sciences Department Medical Affairs Division United Laboratories, Inc. Philippines
Bert Asbild
Board Member
Past-President, The Association for Danish Biomedical Laboratory Scientists
Marie Culliton
President-Elect
Chief Medical Scientist, The National Maternity Hospital, Ireland
Gabriella Lillsunde Larsson
Board Member
Associate Professor, School of Health Sciences Orebro University, Sweden
As above
General Assembly of Delegates
All members associations of IFBLS
At the formal GAD the elected Board of Directors report to Association Members on the IFBLS’s progress since the last meeting and receive feedback from the delegates. The financial report, budget and reports from Open Forum are presented. The new Board of Directors is elected during the GAD.

 Financial information

January
2020
December
2020
90,429
December
2020
440,882
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
86,539
86,539
2,822
2,822
1,068
1,068
90,429
90,429
Congress Fees in odd-number years are received from the Host Country as a one-time payment of $30,000.00 CAD.
Due to the Covid-19 Pandemic, IFBLS did not hold a Congress in 2020

 Membership

Individuals
NGOs
35
39
Private sector entities
0
0
Philanthropic foundations
0
0
Academic institutions
0
0
Government entities
0
0
Intergovernmental organizations
http://ifbls.org/index.php/en/members

Organizational Structure

No data available
No data available

Relations

No data available
No data available

  Activities

To increase recognition and contributions of Biomedical Laboratory Science to improve global health.

To support, advance and promote good scientific laboratory practice through the development and adherence to high quality standards in diverse environments throughout the world.

To support and promote education and advancement of science and technology in the professional development of Biomedical Laboratory Scientists.

To support, advance and promote ethical and professional values in Biomedical Laboratory Science.

To facilitate the exchange of ideas through development of partnerships within the global healthcare community.
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
IFBLS is an association of associations representing Biomedical Laboratory Sciences.